For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
12
views
0
references
 Top references
cited by
1
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      886
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Non-Hodgkin's lymphoma of the thyroid. A clinical study of twenty-two cases.

      Author(s):
      Publication date:
      Journal: Acta Oncologica (Stockholm, Sweden)
      Keywords: Adult, Aged, Aged, 80 and over, Antibiotics, Antineoplastic, administration & dosage, Antineoplastic Agents, Alkylating, Antineoplastic Agents, Hormonal, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Combined Modality Therapy, Cyclophosphamide, Doxorubicin, analogs & derivatives, Female, Follow-Up Studies, Humans, Lymphoma, B-Cell, drug therapy, pathology, radiotherapy, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Non-Hodgkin, Male, Middle Aged, Neoplasm Staging, Prednisolone, Respiratory Sounds, physiopathology, Retrospective Studies, Survival Rate, Thyroid Neoplasms, Vincristine

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Non-Hodgkin's lymphoma (NHL) of the thyroid gland is a rare disease. In the present study, the survival rate and characteristics were retrospectively analyzed in 22 patients with stage IE and IIE thyroid NHL treated with radiotherapy with or without combination chemotherapy. Seventeen NHL had histological evidence of lymphoma of mucosa-associated lymphoid tissue (MALT) type. The 5-year survival rate was 85% in all patients, with 100% and 63% respectively, for stage IE and stage IIE patients. The highly significant factor correlated with decreased determinate survival was concomitant stridor.

          Related collections

          Author and article information

          Journal
          PubMed ID:: 8695161

          ScienceOpen disciplines: Chemistry
          Keywords: Adult,Aged,Aged, 80 and over,Antibiotics, Antineoplastic,administration & dosage,Antineoplastic Agents, Alkylating,Antineoplastic Agents, Hormonal,Antineoplastic Agents, Phytogenic,Antineoplastic Combined Chemotherapy Protocols,therapeutic use,Combined Modality Therapy,Cyclophosphamide,Doxorubicin,analogs & derivatives,Female,Follow-Up Studies,Humans,Lymphoma, B-Cell,drug therapy,pathology,radiotherapy,Lymphoma, B-Cell, Marginal Zone,Lymphoma, Non-Hodgkin,Male,Middle Aged,Neoplasm Staging,Prednisolone,Respiratory Sounds,physiopathology,Retrospective Studies,Survival Rate,Thyroid Neoplasms,Vincristine
          Data availability:
          ScienceOpen disciplines: Chemistry
          Keywords: Adult, Aged, Aged, 80 and over, Antibiotics, Antineoplastic, administration & dosage, Antineoplastic Agents, Alkylating, Antineoplastic Agents, Hormonal, Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Combined Modality Therapy, Cyclophosphamide, Doxorubicin, analogs & derivatives, Female, Follow-Up Studies, Humans, Lymphoma, B-Cell, drug therapy, pathology, radiotherapy, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Non-Hodgkin, Male, Middle Aged, Neoplasm Staging, Prednisolone, Respiratory Sounds, physiopathology, Retrospective Studies, Survival Rate, Thyroid Neoplasms, Vincristine

          Comments

          Comment on this article